Joe Michel Chehade is a Professor of Medicine University of Florida College of Medicine, Jacksonville, Florida.He was the director of Saint Francis Medical Center, Cape Girardeau, MO. May 2000- July 2007 (ADA Accredited Program).South East Missouri Hospital, Cape Girardeau, MO. May 2000-July 2007.Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 1999-2009, Recertification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 2009-2019.He has published 2 book Book Chapters: 1.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Therapy in Type 2 Diabetes in Diabetes in Old Age. 2001 (Second Edition) 199-214; Wiley Publication, Sinclair JA, Finucane P. 2.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Agents for Hyperglycaemia in Diabetes in Old Age. 2009 (Third Edition) 245-264; Wiley Publication, Sinclair JA, Finucane P. He has published 30+ articles.

ongoing research 1. Chehade JM, Haas MJ. Effects of GLP-1 & Exenatide on HDL cholesterol. Amylin Pharmaceuticals, Inc. (21975$). 2. Chehade JM, Mooradian AD. Age-related changes in thyroid hormone action in humans. Dean’s Fund Faculty Research Grant. (9083$).

Prof Muller focuses his research on the potential role of phenolic compounds in the prevention and treatment of metabolic conditions such as insulin resistance, dysbiosis, obesity and type 2 diabetes. He is also involved with a proteomics study to identify early markers for type 2 diabetes. These markers are currently being tested in human subjects. He has 2 International patents (the USA and Europe) for the prevention of diabetes and has authored and co-authored 81 peer-reviewed articles and two book chapters.

Metabolic disease (pathophysiology, prevention, and treatment), phytotherapeutics and early detection of type 2 diabetes.

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society (FCCS) in 2016, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology (FICA) in 2007; (iv) Young Investigator Award by International College of Angiology (2007); (v) Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); (vi) Young Investigator Award by the Society of Experimental Biology and Medicine (2005); (vii) Caroline tum Suden/Frances A Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and (viii) Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). Top 5% of cited authors in journals of Biology and Biochemistry in 2011, by Thomson-Reuters. Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 64-full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as external PhD examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals and granting agencies in United States, United Kingdom, Canada, New Zealand and Poland.

His research is mainly focused on investigating the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.

Born in Germany in 1972. He completed his specialist education at Ege University. During his professional life, she worked as a psychiatric specialist in a general medical hospital, as an associate professor of psychiatry in the second largest mental health hospital in the Turkey. Since 2014, as a professor of psychiatry, she has taught at Üsküdar University and has been working with bipolar disorder in NPIstanbul Brain Hospital. Another area of interest is psychoanalytic psychotherapies.

Bipolar Disorder

Omer Engin is highly affiliated Doctor in Buca Seyfi Demirsoy State Hospital.

Diabetes, Endocrinology

Jose Mario is the Deputy Editor for Diabetes at the Community Forum of healthcare professionals in British Medical Journal. He is an Associate Professor in the Department of Medicine at Universidade Federal Fluminense, and a Senior Staff Physician in the Intensive Care Unit-Adults at Hospital Federal da Lagoa, all in Rio de Janeiro, Brazil. He also has been a principal investigator, and has published clinical studies & Letters to Editors about the mechanisms of cardiovascular diseases associated with type 2 diabetes mellitus in peer reviewed journals like British Medical Journal, Hypertension, New England Journal of Medcine, and American Journal of Hypertension. He was also a post-doctoral Clinical & Research Fellow in the Endocrinology-Diabetes and Hypertension Division of the Brigham & Women´s Hospital at Harvard Medical School where he did many angiotensin II infusions in humans, normotensive, hypertensive, and diabetic individuals. When at Harvard Medical School, he also became certified in the Principles of Epidemiology by the Harvard School of Public Health. He expect for the newer future better prevention and treatment strategies for macrovascular and microvascular diabetic complications, based on more rational and effective strategies. In the University, he is proud of running a busy Hypertension and type 2 diabetes clinic. At British Medical Journal, he enjoy the freedom and internationality of opinions. And also expect a brighter debate about all the clinical future research pathways and controversies surrounding diabetes mellitus.

He has a special interest in type 2 Diabetes, Preventive Cardiology, Hypertension, the renin-angiotensin-aldosterone system and Cardiovascular Diseases associated with Chronic Kidney Diseases.

Ms. Barbara Eichorst is the vice president of Healthy Interactions and Diabetes Educator in Innovex: Sanofi- Aventis.

Diabetes and endocrinology

Dr. Weiqin Chen studied the role of dyslipidemia on diabetic retinopathy, a microvascular complication in diabetic patients with Dr. Julia Busik at Michigan State University and received her PhD degree in Molecular Genetics in 2005. Subsequently, she worked as a Postdoctoral associate for five years with Dr. Lawrence Chan at Baylor College of Medicine, where she was promoted as an instructor in 2010. At BCM, she established two animal models based on genes that are associated with non-alchoholic fatty liver disease (NALFD) and human congenital generalized lipodystrophy (CGL) and characterized their functions in energy metabolism. In 2012, she was recruited as an Assistant Professor in the Department of Physiology at Georgia Regents University. The focus of her current research is to dissect the mechanisms underlying adipose tissue dysfunction and development of obesity and lipodystrophy using both in vivo and in vitro strategies.

besity and its associated health comorbidities are a worldwide epidemic with serious economic and health burden on society. Adipose tissue is an important endocrine organ that plays a key role in the development of obesity and various metabolic disorders. White adipocytes store excess energy in the form of triglycerides for future need. By contrast, brown and beige (browning-in-white) adipocytes metabolize lipid and glucose to produce heat in a process known as nonshivering thermogenesis, which is crucial in systemic energy homeostasis and thermoregulation. Functional brown and beige adipose tissues are highly correlated with body mass index in adult humans and is either reduced or absent in obese and aged individuals and rodents. The long-term research interest in the lab is to understand the regulation of white, beige and brown adipose tissue development and energy homeostasis, and use it to develop potential therapeutic approaches for obesity and related metabolic diseases.

Jose Mario is the Deputy Editor for Diabetes at the Community Forum of healthcare professionals in British Medical Journal. He is an Associate Professor in the Department of Medicine at Universidade Federal Fluminense, and a Senior Staff Physician in the Intensive Care Unit-Adults at Hospital Federal da Lagoa, all in Rio de Janeiro, Brazil. He also has been a principal investigator, and has published clinical studies & Letters to Editors about the mechanisms of cardiovascular diseases associated with type 2 diabetes mellitus in peer reviewed journals like British Medical Journal, Hypertension, New England Journal of Medcine, and American Journal of Hypertension. He was also a post-doctoral Clinical & Research Fellow in the Endocrinology-Diabetes and Hypertension Division of the Brigham & Women´s Hospital at Harvard Medical School where he did many angiotensin II infusions in humans, normotensive, hypertensive, and diabetic individuals. When at Harvard Medical School, he also became certified in the Principles of Epidemiology by the Harvard School of Public Health. He expect for the newer future better prevention and treatment strategies for macrovascular and microvascular diabetic complications, based on more rational and effective strategies. In the University, he is proud of running a busy Hypertension and type 2 diabetes clinic. At British Medical Journal, he enjoy the freedom and internationality of opinions. And also expect a brighter debate about all the clinical future research pathways and controversies surrounding diabetes mellitus.

He has a special interest in type 2 Diabetes, Preventive Cardiology, Hypertension, the renin-angiotensin-aldosterone system and Cardiovascular Diseases associated with Chronic Kidney Diseases.

Dr. Alessandro Antonelli (Associate Professor, MD) has completed his degree in Medicine, cum laude, in 1982, Specialization in Endocrinology in 1985, Specialization in Occupational Health in 1987, and Specialization in Oncology in 1992, at the University of Pisa, Pisa, Italy. He is now working as Associate Professor in the Department of Clinical and Experimental Medicine at the University of Pisa. His researches have been published in more than 280 articles on International journals (Impact Factor > 920, H-I=54). He serves as an Editorial Board Member and is Referee and Reviewer of many scientific international journals.

Endocrinology, Oncology, Occupational Health

Dr. Mandal is is board certified in Internal Medicine and Nephrology (Kidney disease and hypertension). He is an author of many books and published articles on research on diabetes and kidney disease. He is a two-times Fulbright Scholar and a visiting professor of 23 countries which permitted him to lecture on diabetes, high blood pressure and kidney diseases in all five continents of the world. Dr. Anil K. Mandal received Men and Women of Science in 1976, Who’s Who Frontiers in Science and Technology inFebruary 1983, Distinguished Visiting Professor, University of Belgrade, Yogoslavia in October 1985, Received the Fulbright Award 1992-1993 for India in December 20, 1991, Who’s Who in America in 1997, Distinguished Service Award by National Kidney Foundation Of the USA. Philadelphia, PA in October 22, 1998.

The research interest of Mandal is Sugar diabetes is the most common cause of kidney failure in the USA and world wide. This strong association between diabetes and kidney failure has inspired Dr Mandal to develop the frame work of Mandal Diabetes Research foundation to assist diabetic patients to live a good life with medical treatment, and not go to dialysis.

Dr. Rao, Ph.D, worked as professor of Microbiology, Parasitology, Immunology , Pharmacology and Epidemiology in many universities, many medical colleges in India, China, Nepal, Libya, and Philippines. Currently he is working as professor of Microbiology, Parasitology, Immunology and Dean of Student Affairs at Avalon University School of Medicine, Curacao, Netherland Antilles. Dr. Rao has more than 44 years of teaching and research experience. Supervised 4 students for Ph.D, 4 students for M.Phil, 4 students for pre M.Phil degrees. 3 students submitted their Ph.D thesis to Acharya Nagarjuna University, Guntur, Andhra Pradesh, India and waiting for viva examination and degree. Authored 18 text books. Currently USMLE, text books,(CLINICAL Microbiology and CLINICAL Pharmacology) are in press 3 Universities appointed as their advisor and 3 universities honored with fellow ships. Presented 18 full length papers exclusively during 2015 to 2016 in different international journals. Accepted as organizing committee member for 3 international conferences in 2016. Invited Key note speaker and speaker for many conferences, universities and colleges. The Royal Society United kingdom awarded me three fellowships 2016 for my current advanced research in Medicine. Dr Rao is post doctoral supervisor too.

Parasitic infections are more in tropical countries and cause global health problem especially in developing countries, Advanced diagnostics, tests, vaccines, therapeutics and development of new drugs are needed. Viviparity is common among est mammals but not many provide long gestation period, To study long term parasitic toxic effects, it is essential to use long gestation period laboratory animal models. Rats have 21 days, rabbits 30,dog 60 days of gestation period, The subtle effects of Thalidomide tragedy resulting in phocomalia, apoda etc in the offspring lead to untold miseries, Similarly good number of cases of fetal deaths, still births, teratogenices etc. Dr.Rao used scorpion as model in estimation of heavy metals like mercury and lead in embryonic development of scorpion and noticed similar effects, Indeed great challenges, given that most drugs in pipe line failed in clinical trails. Because most of the drugs tested on low gestation period animals, A new thought in the drug design for parasitic diseases by using scorpion as a model. Introducing parasite in scorpion and observing the drug effects and reversal effects, In addition to clinical work, developed a variety of basic and transnational research programs, participated to Ph.D. programs.

M A Hasanat has completed his studies from Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM), Dhaka, Bangladesh. Presently he is a Chairman of Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. He has published about 50 original articles in reputed journals and presented papers at national and international level. He is also a Member of Editorial Board of American Research Journal of Endocrinology

Endocrinology, Diabetes, Gestational Diabetes

Dr. Adel Elnaggar is a medical endocrinologist with an extended expertise in adult diabetes and obesity; as regard prevention and early detection/diagnosis and management and risk reduction of their outcomes. He also share diabetes & obesity clinical trials link and research work concerning both. He is also leadership in community planning against chronic diseases/disabilities affecting community productivity; prevention & management. He is experienced in thyroid diseases and females endocrine health problems.

Diabetes,Obesity,Endocrinology and Psychological aspects of diabetes & obesity management

Deya’s research focuses on gene expression and function in the uterus and its relationship to fertility and cancer. Her clinical interests are Polycystic Ovary Syndrome (PCOS), endometriosis, unexplained infertility and gynaecological cancers (endometrial, ovarian and cervical cancer). She has strategic collaborations with clinicians at Abertawe Bro Morgannwg University NHS health board, developing cellular and molecular approaches to determine mechanisms underlying gynaecological pathologies, to identify biomarkers. Her projects on endometrial implantation and differentiation, relate to L-selectin ligands (MUC1), hormone nuclear receptors and WT1 pathway. Her research in gynaecological cancer includes the regulation of tamoxifen target genes in endometrium and new methods to identify biomarkers for pre-disposition of infertile women to develop gynaecological cancers. She leads an international research network (Prof. Rojas, Catholic University of Maule and Dr. Gracia, Director of Maule Clinic, Chile), studying protein glycation in relation to altered endometrial function. Her aim is to translate basic research into clinically relevant observations for patient benefit. Her projects involve collaboration with the private sector to expedite validation of clinical diagnostic biomarkers and the development of new drug leads for targeted cancer therapy. She also has multidisciplinary collaborations in the area of nanosensors and improved performance medications in the field of human reproductive biology and hormone therapy. She has received research grant valuing over £1m in the recent years. Deya has published more than 20 articles during her career on human, animal, plant and yeast research. She is a member of the Endocrine Society and acts as an expert reviewer for Journal of Clinical Endocrinology and Metabolism, Human Reproduction and others. She teaches within the Genetics & Biochemistry (College of Medicine) and Biomedical Engineering (College of Engineering) undergraduate programmes.

Endocrinology,Biochemistry

J M A Hannan is a Professor and founding Chairman of the Department of Pharmaceutical Sciences at North South University, Dhaka, Bangladesh. He is also a visiting Professor of Department of Pharmacy, Jahangirnagar University, Dhaka and Department of Public Health, NSU. Formerly he was Senior Research Officer in the Department of Pharmacology, BIRDEM, and Dhaka. He was awarded PhD in Pharmacology from University of Ulster, UK. He has published over hundred scientific articles in reputed local and international journals and presented his research findings at various international seminars.

Endocrinology and Diabetes